Viral vectors, especially adenoviral (AdV) vectors, have been in the center of the research endeavor for delivering genes for the past two decades. However, several considerations about AdV vectors, such as pre-existing immunity and targeted delivery, must be appreciated and fully dealt with before their extensive practical application in the fields of vaccination, gene therapy and cancer therapy.

In addition of the company’s R&D on AdV vectors, Ad-Vectors Biotech LLC provides comprehensive adenovirus services for all clients around the world to design and develop AdV vectors and modify their genes (hexon, penton, fiber and IX) for multiple human serotypes and animal serotypes. These unique services could not be provided by any other companies, such as VectorBuilder and Creative Biolabs.